Swiss medical device maker Ypsomed to sell diabetes business
Ypsomed sells diabetes business to TecMed
Keystone-SDA
Select your language
Generated with artificial intelligence.
Listening: Swiss medical device maker Ypsomed to sell diabetes business
Bern-based injection device manufacturer Ypsomed announced on Tuesday that it was selling its diabetes-related activities to another Swiss company TecMed. The transaction is worth CHF420 million ($517 million).
This content was published on
1 minute
Keystone-SDA
Français
fr
Ypsomed cède les activités liées au diabète à TecMed
Original
“Proceeds from the sale will finance the expansion of the injection systems business,” said a statement. The transaction is expected to be completed in the second half of the year, subject to regulatory approval of the ongoing demerger.
In November, the company announced the start of the process of selling its diabetes care business. Following a comprehensive marketing phase involving both strategic and financial buyers, TecMed “emerged as the ideal partner to take over Ypsomed’s diabetes care business”.
Translated from German by DeepL/jdp
How we work
We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. An editor then briefly reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
Did you find this explanation helpful? Please fill out this short survey to help us understand your needs by clicking hereExternal link.
External Content
Popular Stories
More
Life & Aging
Zurich: how the world capital of housing shortages is tackling the problem
Living longer: What do you think about the longevity trend?
The longevity market is booming thanks in part to advances in the science of ageing. What do you think of the idea of significantly extending human lifespan?
Basel prepares 700 volunteers for the Eurovision Song Contest
This content was published on
Around 320 people took part in one of the two official information events for the Eurovision Song Contest (ESC) in Basel on Friday.
More Swiss soldiers involved in accidents during training in Austria
This content was published on
The Swiss army has reported various accidents involving Swiss soldiers during the exercise “TRIAS 25” in Austria. Some have led to hospitalisations.
Swiss court rules vegan meat substitutes can’t use animal names
This content was published on
Vegan meat substitutes may not bear animal names such as “planted.chicken” according to a ruling by the Swiss Federal Supreme Court.
Swiss cantons spared duty to create new traveller transit sites
This content was published on
Swiss cantons will no longer be formally obliged by the government to create new transit sites for the travelling community.
Swiss politicians bemoan limited access to EU treaty details
This content was published on
Protests that only a few Swiss parliamentarians will be able to read the contents of a new agreement negotiated with the EU.
This content was published on
For the first time, most Swiss residents favour withdrawing their pension pot as a lump-sum over regular annuity payments.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.